Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Therapeutic Plenary Session 1103

Device-Aided and Surgical Therapies for Parkinson’s Disease

Sunday, October 5, 2025
13:30 - 15:00 | Room TBD
Clinical

In this session, the faculty will present an in-depth exploration of device-aided and surgical therapies for Parkinson’s disease. A practical approach on patient selection with Illustrative video cases will be discussed.


Chairs:
Jose Obeso, Spain
Mayela Rodriguez Violante, Mexico

Presenters:

Apomorphine Therapies and Levodopa Infusions
K Ray Chaudhuri, United Kingdom

DBS and MRgFUS
Elena Moro, France

Criteria for Patient Selection
Thomas Kimber, Australia

CSPC Liaisons:
Mayela Rodriguez Violante, Mexico

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Analyze efficacy, tolerability, and safety of apomorphine therapies and levodopa infusions in Parkinson’s disease
  2. Analyze efficacy, tolerability, and safety of DBS and MR-guided focused ultrasound in Parkinson’s disease
  3. Assess the criteria for patient selection for each of these methods

Recommended Audience
Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level
Advanced / Expert
Beginner / Foundational
Intermediate / Experienced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice